Saad Urrehman Gilani
Head-Equity Investments bei Yorkville Advisors LLC
Profil
Mr. Saad Urrehman Gilani is a Managing Director at Yorkville Advisors LLC.
He is on the Board of Directors at Temple Therapeutics BV.
He is a member of the firm’s Investment Committee.
He also sits on the supervisory boards of Cyxone AB based in Sweden and Temple Therapeutics BV based in the Netherlands.
Prior to joining Yorkville, Mr. Gilani worked at Keyence Corporation for over 11 years where he held various management roles within the Engineering and Marketing groups.
He earned a BS in Electrical Engineering and received his MBA from Rutgers Business School where he specialized in finance.
Aktive Positionen von Saad Urrehman Gilani
| Unternehmen | Position | Beginn |
|---|---|---|
Yorkville Advisors LLC
 Yorkville Advisors LLC Investment ManagersFinance Yorkville Advisors LLC (Yorkville) is an independent alternative investment manager headquartered in Mountainside, New Jersey. The firm was founded by Mark A. Angelo in 2001. Yorkville serves as a global investment manager to a number of private investment funds. | Head-Equity Investments | 01.01.2005 |
Temple Therapeutics BV
 Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Director/Board Member | 01.07.2015 |
Ehemalige bekannte Positionen von Saad Urrehman Gilani
| Unternehmen | Position | Ende |
|---|---|---|
| KEYENCE CORPORATION | Corporate Officer/Principal | - |
| CYXONE AB | Director/Board Member | - |
Ausbildung von Saad Urrehman Gilani
| Rutgers State University of New Jersey | Masters Business Admin |
| Rutgers University School of Engineering | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KEYENCE CORPORATION | Electronic Technology |
| CYXONE AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Yorkville Advisors LLC
Yorkville Advisors LLC Investment ManagersFinance Yorkville Advisors LLC (Yorkville) is an independent alternative investment manager headquartered in Mountainside, New Jersey. The firm was founded by Mark A. Angelo in 2001. Yorkville serves as a global investment manager to a number of private investment funds. | Finance |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Health Technology |
